Aurobindo PharmaAUROPHARMA 
$18.63-0.07%24h
-0.07%24h
Global rank1478
Market cap$10.92B
Change 7d2.23%
YTD Performance44.06%
SP500 benchmarkOutperform
P/E0.57
P/S3.72
Revenue$2.93B
Earnings$229.78M
Dividend yield-
Main Sector
Healthcare
EPS for Aurobindo Pharma (AUROPHARMA)
Aurobindo Pharma has an EPS of $32.9. In 2022, the company made an earnings per share (EPS) of $45.19. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for AUROPHARMA
-
Value:-
EPS history for Aurobindo Pharma from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | $32.90 | -27.20% |
| 2022 | $45.19 | -50.37% |
| 2021 | $91.05 | 87.50% |
| 2020 | $48.56 | - |
View the highest EPS stocks
